Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Vincristine therapy for severe platelet alloimmunization.

C S Bruggers¹, J Kurtzberg, H S Friedman

¹Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710.

The American Journal of Pediatric Hematology/Oncology

|January 1, 1991

Summary

Vincristine effectively treated severe platelet alloimmunization in a child with aplastic anemia. This vincristine treatment improved platelet transfusion response and reduced bleeding episodes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data.

ESMO open·2024

Same author

Meta-analyses of the efficacy of pharmacotherapies and sublingual allergy immunotherapy tablets for allergic rhinitis in adults and children.

Rhinology·2021

Same author

Exploring factors associated with health disparities in asthma and poorly controlled asthma among school-aged children in the U.S.

The Journal of asthma : official journal of the Association for the Care of Asthma·2019

Same author

The national burden of poorly controlled asthma, school absence and parental work loss among school-aged children in the United States.

The Journal of asthma : official journal of the Association for the Care of Asthma·2017

Same author

Assessment of treatment patterns associated with injectable disease-modifying therapy among relapsing-remitting multiple sclerosis patients.

Multiple sclerosis journal - experimental, translational and clinical·2017

Same author

Personality dimensions and measures potentially relevant to health: A focus on hostility.

Annals of behavioral medicine : a publication of the Society of Behavioral Medicine·2013

Area of Science:

Hematology
Immunology
Pediatric Oncology

Background:

Idiopathic severe aplastic anemia (SAA) can be refractory to standard immunosuppressive therapy.
Platelet alloimmunization is a significant complication in patients requiring frequent transfusions, leading to refractoriness to human leukocyte antigen (HLA)-matched products.
Severe bleeding episodes are a major concern in patients with alloimmune thrombocytopenia.

Observation:

A 19-month-old girl with SAA refractory to immunosuppressive therapy developed severe platelet alloimmunization.
The patient became refractory to HLA-matched platelet transfusions and experienced recurrent bleeding.
Intravenous vincristine therapy was initiated weekly for three doses.

Findings:

Vincristine treatment led to marked clinical and laboratory improvement in platelet transfusion response.

Related Experiment Videos

Discontinuation of vincristine resulted in a return of refractoriness to HLA-matched platelets.

Reinstitution of vincristine resolved bleeding and restored transfusion efficacy.

Implications:

Vincristine may be a novel therapeutic option for alloimmune thrombocytopenia, particularly in refractory cases.
The mechanism may involve targeted drug delivery to macrophages involved in antibody production.
This case highlights a potential treatment strategy for a challenging complication in transfusion-dependent patients.